Cargando…
Patient Preferences Associated with Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
PURPOSE: To evaluate treatment-related preferences among patients receiving intravitreal anti-vascular endothelial growth factor (VEGF) therapy for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME). PATIENTS AND METHODS: We conducted a prospective survey of patients...
Autores principales: | Bhagat, Davis, Kirby, Breanne, Bhatt, Harit, Jager, Rama, George, Meena, Sheth, Veeral |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534869/ https://www.ncbi.nlm.nih.gov/pubmed/33061283 http://dx.doi.org/10.2147/OPTH.S273564 |
Ejemplares similares
-
New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021) -
Faricimab for the Treatment of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration
por: Ferro Desideri, Lorenzo, et al.
Publicado: (2023) -
Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of Neovascularization
por: Yu, Hannah J., et al.
Publicado: (2020) -
Telemedicine for Retinal Disease During the COVID-19 Pandemic: Survey of the Patient Perspective
por: Patel, Prem N., et al.
Publicado: (2022) -
Brolucizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Ophthalmology and Diabetology Treatment Aspects
por: Garweg, Justus G., et al.
Publicado: (2023)